(Q43955159)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8256898%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8256898%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8256898%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

author name string

Fox R

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8256898%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Kisyombe GM

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8256898%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Saruni AO

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8256898%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Uiso LO

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8256898%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Ramsay AR

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8256898%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Ngowi FI

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8256898%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Gillespie SH

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8256898%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

publication date

1 December 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8256898%20AND%20SRC:MED&resulttype=core&format=json

The American Review of Respiratory Disease

28 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8256898%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

148

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8256898%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

1547-1551

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8256898%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

6 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8256898%20AND%20SRC:MED&resulttype=core&format=json

An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome

28 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.6_PT_1.1547

Tuberculosis. Back to a frightening future

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.6_PT_1.1547

Comparative in-vitro activity of five fluoroquinolones against mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.6_PT_1.1547

Mycobacteria and the new quinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.6_PT_1.1547

In vitro and in vivo activities of sparfloxacin (AT-4140) against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.6_PT_1.1547

In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.6_PT_1.1547

In-vitro activity of ofloxacin against Mycobacterium tuberculosis and its clinical efficacy in multiply resistant pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.6_PT_1.1547

The action of antituberculosis drugs in short-course chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.6_PT_1.1547

The role of pyrazinamide in primary chemotherapy for pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.6_PT_1.1547

Human immunodeficiency virus infection in tuberculosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.6_PT_1.1547

Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.6_PT_1.1547

Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.6_PT_1.1547

Community-based short-course treatment of pulmonary tuberculosis in a developing nation. Initial report of an eight-month, largely intermittent regimen in a population with a high prevalence of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.6_PT_1.1547

Familial dysalbuminemic hyperthyroxinemia associated with primary thyroid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.6_PT_1.1547

10.1164/AJRCCM/148.6_PT_1.1547

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8256898%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference